Publications

Profiling of Tumor-Infiltrating Immune Cells and Their Impact on Survival in Glioblastoma Patients Undergoing Immunotherapy with Dendritic Cells

Peres N. et al, (2024), International Journal of Molecular Sciences, 25, 5275 - 5275

A robust deep learning workflow to predict CD8 + T-cell epitopes.

Lee CH. et al, (2023), Genome Med, 15

Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial

Lepski G. et al, (2023), Cancers, 15, 1239 - 1239

A robust deep learning platform to predict CD8+ T-cell epitopes

Lee CH. et al, (2022)

Decitabine increases neoantigen and cancer testis antigen expression to enhance T-cell-mediated toxicity against glioblastoma.

Ma R. et al, (2022), Neuro Oncol, 24, 2093 - 2106

Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence

Pinho MP. et al, (2022), International Journal of Molecular Sciences, 23, 5396 - 5396

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity.

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium. Electronic address: julian.knight@well.ox.ac.uk None. and COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None., (2022), Cell, 185, 916 - 938.e58

HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses.

Buckley PR. et al, (2022), Immunology

HLA-dependent variation in SARS-CoV-2 CD8+ T cell cross-reactivity with human coronaviruses

Buckley PR. et al, (2021)

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

COvid-19 Multi-omics Blood ATlas (COMBAT) Consortium None. et al, (2021)

CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains and influenza virus

Lee C. et al, (2020)

Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains.

Lee CH. et al, (2020), Front Immunol, 11

Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response.

Pinho MP. et al, (2019), Oncoimmunology, 8

Commentary: Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells.

Pinho MP. and Barbuto JAM., (2018), Front Immunol, 9

Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy.

Patente TA. et al, (2018), Frontiers in immunology, 9

Cationic liposomes produced via ethanol injection method for dendritic cell therapy.

Vitor MT. et al, (2017), J Liposome Res, 27, 249 - 263

Abstracts from the 4th ImmunoTherapy of Cancer Conference : Prague, Czech Republic. 20–22 March 2017

Ženka J. et al, (2017), Journal for immunotherapy of cancer, 5

Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.

Pinho MP. et al, (2016), Cytotherapy, 18, 570 - 580

Dendritic Cells Stimulated by Cationic Liposomes.

Vitor MT. et al, (2016), J Nanosci Nanotechnol, 16, 270 - 279

Tolerogenic IDO(+) Dendritic Cells Are Induced by PD-1-Expressing Mast Cells.

Rodrigues CP. et al, (2016), Front Immunol, 7

Cookies on this website